M, V., BL, C., IJ, K., ZM, M., AS, D., PS, J., . . . SD, S. (2025). Effects of the Nonsteroidal MRA Finerenone With and Without Concomitant SGLT2 Inhibitor Use in Heart Failure. Circulation, 151(2), 149. https://doi.org/10.1161/CIRCULATIONAHA.124.072055
Chicago Style (17th ed.) CitationM, Vaduganathan, et al. "Effects of the Nonsteroidal MRA Finerenone With and Without Concomitant SGLT2 Inhibitor Use in Heart Failure." Circulation 151, no. 2 (2025): 149. https://doi.org/10.1161/CIRCULATIONAHA.124.072055.
MLA (9th ed.) CitationM, Vaduganathan, et al. "Effects of the Nonsteroidal MRA Finerenone With and Without Concomitant SGLT2 Inhibitor Use in Heart Failure." Circulation, vol. 151, no. 2, 2025, p. 149, https://doi.org/10.1161/CIRCULATIONAHA.124.072055.